CML-674 Molecular Screening of Tyrosine Kinase Inhibitor Resistance in Tunisian Patients With Chronic Myeloid Leukemia

Health-Related Quality of Life and Financial Burden of Ethiopian Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors

POSTER: ALL-022 Assessment of Molecular Response to Tyrosine Kinase Inhibitors in Tunisian Patients With Ph+ Acute Lymphoblastic Leukemia

Evaluation of the Imatinib Treatment of Patients with Chronic Myeloid Leukemia (CML). a Retrospective Study from Algerian Working Group on CML (GAT-LMC)

Abstract Introduction: The advent of anti-tyrosine kinase has revolutionized the tr

hOCT1 gene expression predict for optimal response to Imatinib in Tunisian patients with chronic myeloid leukemia

International audience Imatinib mesylate (IM) is considered as a highly effective the

Molecular Profiling of Kenyan Acute Myeloid Leukemia Patients

Acute myeloid leukemia (AML) is an infrequent disease, and it is associated with high morbidity and

Detection of Methylene Tetrahydrofolate Reductase Gene Polymorphism (C677T) In Sudanese Patients with Chronic Myeloid Leukemia

Chronic myeloid leukaemia (CML) is a kind of cancer that affects the white blood cells and resort to